DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

K-TAB (Potassium Chloride) - Side Effects and Adverse Reactions

 



ADVERSE REACTIONS

One of the most severe adverse effects is hyperkalemia (see CONTRAINDICATIONS, WARNINGS, and OVERDOSAGE). There also have been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation (see CONTRAINDICATIONS and WARNINGS).

The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. These symptoms are due to irritation of the gastrointestinal tract and are best managed by taking the dose with meals, or reducing the amount taken at one time.

Skin rash has been reported rarely.



REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO K-TAB

Below is a sample of reports where side effects / adverse reactions may be related to K-TAB. The information is not vetted and should not be cosidered as verified clinical evidence.

Possible K-TAB side effects / adverse reactions in 73 year old male

Reported by a physician from United States on 2007-04-26

Patient: 73 year old male

Reactions: Mean Arterial Pressure Decreased, Dyspnoea, Hyperkalaemia, Atrioventricular Block Complete, Atrial Fibrillation, Bradycardia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Dabigatran Etexilate
    Indication: Drug USE FOR Unknown Indication

K-TAB
    Indication: Electrolyte Substitution Therapy
    Start date: 2007-03-07
    End date: 2007-03-29

Spironolactone
    Indication: Cardiac Failure Congestive
    Start date: 2006-05-14
    End date: 2007-03-29

Other drugs received by patient: Bumetanide; Lisinopril



See index of all K-TAB side effect reports >>

Drug label data at the top of this Page last updated: 2006-09-19

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009